Acadia Pharmaceuticals | Créances Commerciales



Trade Debtors Changement Date
Acadia Pharmaceuticals USD 104.7M 5.67M 2024-12
ALKERMES USD 394.72M 24.54M 2024-12
Alnylam Pharmaceuticals USD 405.31M 51.46M 2024-12
Biogen USD 1.87B 119.3M 2024-12
BioMarin Pharmaceutical USD 660.54M 117.01M 2024-12
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Corcept Therapeutics USD 53.98M 5.74M 2024-12
Cytokinetics USD 16.65M 16.41M 2024-12
Eisai JPY 235.64B 40.42B 2024-12
Eli Lilly USD 14B 727.8M 2025-03
Incyte USD 823.13M 30.02M 2025-03
J&J USD 16.02B 1.18B 2025-03
Moderna USD 306M 286M 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Prothena USD 0 0 2024-12
PTC Therapeutics USD 158.55M 41.42M 2024-12
Sarepta Therapeutics USD 649.73M 133.74M 2024-12
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Acadia Pharmaceuticals Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.